Skip to main content
Fig. 1 | Arthritis Research & Therapy

Fig. 1

From: Extracellular matrix turnover biomarkers reflect pharmacodynamic effects and treatment response of adalimumab in patients with axial spondyloarthritis—results from two randomized controlled trials

Fig. 1

Study design for the DANISH and ASIM studies. Red triangles represent the visits where serum was collected. For the DANISH study, when analyzing the response to treatment, data of the placebo group at week 12 was considered week 0, and data from week 24 was considered week 12

Back to article page

Arthritis Research & Therapy

ISSN: 1478-6362

Contact us